Zurueck zur Suche

Reporte zur Charge U039260

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

3Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
MA 1 WV 1 MI 1

VAERS 2401346

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U039260

mild
Staat
MA
Alter
4,0
Geschlecht
F
Eingang
04.08.2022
Impfdatum
02.08.2022
Beginn
04.08.2022
Tage bis Beginn
2,0
Dosis
1
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Cellulitis Erythema Injection site swelling

Symptomtext

Patient presented with arm redness and red streak along with arm swelling at injection site, two days after administration of routine 4 year old vaccine. Patient is being treated for cellulitis of left arm with Clindamycin 225 mg orally 3 times a day.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site swelling
Hospital-Tage
-
Labordaten
Examination of left arm by provider. No lab test performed.
Aktuelle Erkrankungen
Congenital hear Disease, Congestive Heart Failure, Tricuspid atresia, Pulmonary Hypertension
Vorgeschichte
Congenital hear Disease, Congestive Heart Failure, Tricuspid atresia, Pulmonary Hypertension
Andere Medikamente
None
Allergien
No known allergies
Vorherige Impfungen
-

VAERS 2520413

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U039260

gering
Staat
WV
Alter
40,0
Geschlecht
M
Eingang
01.12.2022
Impfdatum
19.08.2022
Beginn
19.08.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Wrong product administered

Symptomtext

No additional AE details were provided and no additional AE's were reported; male patient came in to receive a dose of MMR-II and VARIVAX because he had low titers and received PROQUAD; This spontaneous report has been received from a licensed practical nurse, referring to a 40 years old male patient. Information regarding the patient's pertinent medical history, concurrent condition and concomitant medication was not provided. The reporter stated that the patient came in to receive a dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (dose, route, lot number and expiration date were not reported) and varicella virus vaccine live (oka/merck) (VARIVAX) (dose, route, lot number and expiration date were not reported) because he had low titers, but he received measles, mumps, rubella and varicella (oka-merck) virus vaccine live (recombinant Human albumin (rHA)) (PROQUAD) (dose: 0.5ml, lot # U039260 with expiration date: 03-APR-2023) subcutaneously instead on 19-AUG-2022 (wrong product administered). The strength was unknown for all suspect vaccines. The indication for suspect vaccines was prophylaxis. No additional adverse event (AE) details were provided and no additional AE's were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2417583

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U039260

gering
Staat
MI
Alter
4,0
Geschlecht
F
Eingang
22.08.2022
Impfdatum
18.08.2022
Beginn
18.08.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Extra dose administered

Symptomtext

Pt was given her 4year immunizations twice.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-